{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T12:25:06Z","timestamp":1794313506695,"version":"4.9.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00198-026-08161-9","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T06:47:16Z","timestamp":1785912436000},"page":"2651-2662","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Low alkaline phosphatase in adults: implications for the diagnosis of hypophosphatasia during evaluation for osteoporosis"],"prefix":"10.1007","volume":"37","author":[{"given":"Leonhard S.","family":"Hummel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Blaschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Lamersdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Kornak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8366-8625","authenticated-orcid":false,"given":"Heide","family":"Siggelkow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"8161_CR1","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1469-1809.2011.00642.x","volume":"75","author":"E Mornet","year":"2011","unstructured":"Mornet E, Yvard A, Taillandier A, Fauvert D, Simon-Bouy B (2011) A molecular-based estimation of the prevalence of hypophosphatasia in the European population. Ann Hum Genet 75:439\u2013445","journal-title":"Ann Hum Genet"},{"key":"8161_CR2","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41431-020-00732-6","volume":"29","author":"E Mornet","year":"2021","unstructured":"Mornet E, Taillandier A, Domingues C et al (2021) Hypophosphatasia: a genetic-based nosology and new insights in genotype-phenotype correlation. Eur J Hum Genet 29:289\u2013299","journal-title":"Eur J Hum Genet"},{"key":"8161_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.2056","volume":"11","author":"NM Beck","year":"2023","unstructured":"Beck NM, Sagaser KG, Lawson CS, Hertenstein C, Jachens A, Forster KR, Miller KA, Jelin AC, Blakemore KJ, Hoover-Fong J (2023) Not just a carrier: clinical presentation and management of patients with heterozygous disease-causing alkaline phosphatase (ALPL) variants identified through expanded carrier screening. Mol Genet Genomic Med 11:e2056","journal-title":"Mol Genet Genomic Med"},{"key":"8161_CR4","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s00223-015-0079-1","volume":"98","author":"JL Mill\u00e1n","year":"2016","unstructured":"Mill\u00e1n JL, Whyte MP (2016) Alkaline phosphatase and hypophosphatasia. Calcif Tissue Int 98:398\u2013416","journal-title":"Calcif Tissue Int"},{"key":"8161_CR5","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1007\/s00198-015-3272-1","volume":"26","author":"ML Bianchi","year":"2015","unstructured":"Bianchi ML (2015) Hypophosphatasia: an overview of the disease and its treatment. Osteoporos Int 26:2743\u20132757","journal-title":"Osteoporos Int"},{"key":"8161_CR6","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s00198-020-05345-9","volume":"31","author":"ML Bianchi","year":"2020","unstructured":"Bianchi ML, Bishop NJ, Gua\u00f1abens N, Hofmann C, Jakob F, Roux C, Zillikens MC (2020) Hypophosphatasia in adolescents and adults: overview of diagnosis and treatment. Osteoporosis international\u202f: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 31:1445\u20131460","journal-title":"Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"key":"8161_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ymgme.2017.07.010","volume":"122","author":"PS Kishnani","year":"2017","unstructured":"Kishnani PS, Rush ET, Arundel P et al (2017) Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa. Mol Genet Metab 122:4\u201317","journal-title":"Mol Genet Metab"},{"key":"8161_CR8","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1007\/s00198-017-4087-z","volume":"28","author":"T Schmidt","year":"2017","unstructured":"Schmidt T, Mussawy H, Rolvien T, Hawellek T, Hubert J, R\u00fcther W, Amling M, Barvencik F (2017) Clinical, radiographic and biochemical characteristics of adult hypophosphatasia. Osteoporos Int 28:2653\u20132662","journal-title":"Osteoporos Int"},{"key":"8161_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/jbmr\/zjaf124","volume":"41","author":"R Montero-Lopez","year":"2026","unstructured":"Montero-Lopez R, Farman MR, H\u00f6gler F et al (2026) Biochemical phenotype of hypophosphatasia in asymptomatic individuals carrying ALPL variants. J Bone Miner Res 41:259\u2013269","journal-title":"J Bone Miner Res"},{"key":"8161_CR10","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12891-019-2420-8","volume":"20","author":"W H\u00f6gler","year":"2019","unstructured":"H\u00f6gler W, Langman C, Da Gomes SH, Fang S, Linglart A, Ozono K, Petryk A, Rockman-Greenberg C, Seefried L, Kishnani PS (2019) Diagnostic delay is common among patients with hypophosphatasia: initial findings from a longitudinal, prospective, global registry. BMC Musculoskelet Disord 20:80","journal-title":"BMC Musculoskelet Disord"},{"key":"8161_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ejim.2015.12.019","volume":"29","author":"L Riancho-Zarrabeitia","year":"2016","unstructured":"Riancho-Zarrabeitia L, Garc\u00eda-Unzueta M, Tenorio JA, G\u00f3mez-Gerique JA, Ruiz P\u00e9rez VL, Heath KE, Lapunzina P, Riancho JA (2016) Clinical, biochemical and genetic spectrum of low alkaline phosphatase levels in adults. Eur J Intern Med 29:40\u201345","journal-title":"Eur J Intern Med"},{"key":"8161_CR12","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/jbmr.1565","volume":"27","author":"RAL Sutton","year":"2012","unstructured":"Sutton RAL, Mumm S, Coburn SP, Ericson KL, Whyte MP (2012) \u201cAtypical femoral fractures\u201d during bisphosphonate exposure in adult hypophosphatasia. J Bone Miner Res 27:987\u2013994","journal-title":"J Bone Miner Res"},{"key":"8161_CR13","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1002\/jbmr.3226","volume":"32","author":"JR Shapiro","year":"2017","unstructured":"Shapiro JR, Lewiecki EM (2017) Hypophosphatasia in adults: clinical assessment and treatment considerations. J Bone Miner Res 32:1977\u20131980","journal-title":"J Bone Miner Res"},{"key":"8161_CR14","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1359\/jbmr.081253","volume":"24","author":"MP Whyte","year":"2009","unstructured":"Whyte MP (2009) Atypical femoral fractures, bisphosphonates, and adult hypophosphatasia. J Bone Miner Res 24:1132\u20131134","journal-title":"J Bone Miner Res"},{"key":"8161_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11914-016-0309-0","volume":"14","author":"A Linglart","year":"2016","unstructured":"Linglart A, Biosse-Duplan M (2016) Hypophosphatasia. Curr Osteoporos Rep 14:95\u2013105","journal-title":"Curr Osteoporos Rep"},{"key":"8161_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0009-8981(83)90077-3","volume":"127","author":"YS Shin","year":"1983","unstructured":"Shin YS, Rasshofer R, Friedrich B, Endres W (1983) Pyridoxal-5\u2019-phosphate determination by a sensitive micromethod in human blood, urine and tissues; its relation to cystathioninuria in neuroblastoma and biliary atresia. Clin Chim Acta 127:77\u201385","journal-title":"Clin Chim Acta"},{"key":"8161_CR17","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/BF02263621","volume":"4","author":"YS Shin-Buehring","year":"1981","unstructured":"Shin-Buehring YS, Rasshofer R, Endres W (1981) A new enzymatic method for pyridoxal-5-phosphate determination. J Inherit Metab Dis 4:123\u2013124","journal-title":"J Inherit Metab Dis"},{"key":"8161_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1146\/annurev-nutr-071714-034330","volume":"35","author":"PM Ueland","year":"2015","unstructured":"Ueland PM, Ulvik A, Rios-Avila L, Midttun \u00d8, Gregory JF (2015) Direct and functional biomarkers of vitamin B6 status. Annu Rev Nutr 35:33\u201370","journal-title":"Annu Rev Nutr"},{"key":"8161_CR19","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00198-007-0543-5","volume":"19","author":"JA Kanis","year":"2008","unstructured":"Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E (2008) FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19:385\u2013397","journal-title":"Osteoporos Int"},{"key":"8161_CR20","unstructured":"DVO (2017) Prophylaxe, Diagnostik und Therapie der Osteoporose bei postmenopausalen Frauen und bei M\u00e4nnern. S3-Leitlinie des Dachverbands der Deutschsprachigen Wissenschaftlichen Osteologischen Gesellschaften e.V. https:\/\/dv-osteologie.org\/uploads\/Leitlinie%202017\/Finale%20Version%20Leitlinie%20Osteoporose%202017_end.pdf. Accessed 20 June 2022"},{"key":"8161_CR21","doi-asserted-by":"publisher","first-page":"e3048","DOI":"10.1210\/clinem\/dgac147","volume":"107","author":"R Oheim","year":"2022","unstructured":"Oheim R, Tsourdi E, Seefried L et al (2022) Genetic diagnostics in routine osteological assessment of adult low bone mass disorders. J Clin Endocrinol Metab 107:e3048\u2013e3057","journal-title":"J Clin Endocrinol Metab"},{"key":"8161_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2023.116947","volume":"178","author":"MR Farman","year":"2024","unstructured":"Farman MR, Rehder C, Malli T et al (2024) The Global ALPL gene variant classification project: dedicated to deciphering variants. Bone 178:116947","journal-title":"Bone"},{"key":"8161_CR23","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00198-023-06844-1","volume":"35","author":"AA Khan","year":"2024","unstructured":"Khan AA, Brandi ML, Rush ET et al (2024) Hypophosphatasia diagnosis: current state of the art and proposed diagnostic criteria for children and adults. Osteoporos Int 35:431\u2013438","journal-title":"Osteoporos Int"},{"key":"8161_CR24","doi-asserted-by":"publisher","DOI":"10.1530\/EC-25-0048","author":"A Frank","year":"2025","unstructured":"Frank A, Witzel JC, Heppner C, Lamersdorf A, Leha A, Siggelkow H (2025) German DVO risk score identified more patients requiring treatment compared to FRAX. Endocr Connect 14(5):e250048","journal-title":"Endocr Connect"},{"key":"8161_CR25","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1055\/a-1977-4413","volume":"131","author":"JC Witzel","year":"2023","unstructured":"Witzel JC, Giessel A, Heppner C, Lamersdorf A, Leha A, Gluer CC, Siggelkow H (2023) Discrepancies between osteoporotic fracture evaluations in men based on German (DVO) osteoporosis guidelines or the FRAX score. Exp Clin Endocrinol Diabetes 131:114\u2013122","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"8161_CR26","doi-asserted-by":"publisher","first-page":"230","DOI":"10.11138\/ccmbm\/2017.14.1.230","volume":"14","author":"F Conti","year":"2017","unstructured":"Conti F, Ciullini L, Pugliese G (2017) Hypophosphatasia: clinical manifestation and burden of disease in adult patients. Clinical cases in mineral and bone metabolism\u202f: the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases 14:230\u2013234","journal-title":"Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases"},{"key":"8161_CR27","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s00223-020-00771-7","volume":"108","author":"NM Jandl","year":"2021","unstructured":"Jandl NM, Schmidt T, Rolvien T et al (2021) Genotype-phenotype associations in 72 adults with suspected ALPL-associated hypophosphatasia. Calcif Tissue Int 108:288\u2013301","journal-title":"Calcif Tissue Int"},{"key":"8161_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-024-09906-7","volume":"51","author":"L Seefried","year":"2024","unstructured":"Seefried L, Petryk A, Del Angel G, Reder F, Bauer P (2024) Whole genome sequencing in adults with clinical hallmarks of hypophosphatasia negative for ALPL variants. Mol Biol Rep 51:984","journal-title":"Mol Biol Rep"},{"key":"8161_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.63781","volume":"194","author":"PS Kishnani","year":"2024","unstructured":"Kishnani PS, Seefried L, Dahir KM et al (2024) New insights into the landscape of ALPL gene variants in patients with hypophosphatasia from the Global HPP Registry. Am J Med Genet A 194:e63781","journal-title":"Am J Med Genet A"},{"key":"8161_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10223","volume":"3","author":"K Rassie","year":"2019","unstructured":"Rassie K, Dray M, Michigami T, Cundy T (2019) Bisphosphonate use and fractures in adults with hypophosphatasia. JBMR Plus 3:e10223","journal-title":"JBMR Plus"},{"key":"8161_CR31","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1007\/s00198-018-4571-0","volume":"29","author":"L L\u00f3pez-Delgado","year":"2018","unstructured":"L\u00f3pez-Delgado L, Riancho-Zarrabeitia L, Garc\u00eda-Unzueta MT, Tenorio JA, Garc\u00eda-Hoyos M, Lapunzina P, Valero C, Riancho JA (2018) Abnormal bone turnover in individuals with low serum alkaline phosphatase. Osteoporos Int 29:2147\u20132150","journal-title":"Osteoporos Int"},{"key":"8161_CR32","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1136\/annrheumdis-2019-eular.7535","volume":"78","author":"C Tornero","year":"2019","unstructured":"Tornero C, Coronado M, Humbert L, Garc\u00eda-Carazo S, Lancha C, Monachello D, Dominguez-Gadea L, Balsa A, Aguado P (2019) AB1184 bone mineral density, trabecular bone score and 3D-DXA assessment in adult patientswith a positive and negative genetical testing for hypophosphatasia. Ann Rheum Dis 78:2053","journal-title":"Ann Rheum Dis"},{"key":"8161_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jbmr.1998","volume":"29","author":"E Shane","year":"2014","unstructured":"Shane E, Burr D, Abrahamsen B et al (2014) Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 29:1\u201323","journal-title":"J Bone Miner Res"},{"key":"8161_CR34","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1055\/a-2127-2927","volume":"149","author":"H Siggelkow","year":"2024","unstructured":"Siggelkow H, Thomasius F (2024) Osteoporosis - implications of the new guidelines in practice. Dtsch Med Wochenschr 149:684\u2013689","journal-title":"Dtsch Med Wochenschr"},{"key":"8161_CR35","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.bone.2016.10.022","volume":"94","author":"B Mentrup","year":"2017","unstructured":"Mentrup B, Girschick H, Jakob F, Hofmann C (2017) A homozygous intronic branch-point deletion in the ALPL gene causes infantile hypophosphatasia. Bone 94:75\u201383","journal-title":"Bone"},{"key":"8161_CR36","doi-asserted-by":"publisher","first-page":"324","DOI":"10.11138\/ccmbm\/2017.14.3.324","volume":"14","author":"F Marini","year":"2017","unstructured":"Marini F, Brandi ML (2017) Atypical femur fractures: a distinctive tract of adult hypophosphatasia. Clin Cases Miner Bone Metab 14:324\u2013328","journal-title":"Clin Cases Miner Bone Metab"},{"key":"8161_CR37","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/jbmr\/zjae177","volume":"40","author":"F Bertoldo","year":"2024","unstructured":"Bertoldo F, Tripepi G, Zaninotto M et al (2024) Possible role of bone turnover markers in the diagnosis of adult hypophosphatasia. J Bone Miner Res 40:79\u201386","journal-title":"J Bone Miner Res"},{"key":"8161_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-022-02393-8","volume":"17","author":"KM Dahir","year":"2022","unstructured":"Dahir KM, Seefried L, Kishnani PS, Petryk A, H\u00f6gler W, Linglart A, Martos-Moreno G\u00c1, Ozono K, Fang S, Rockman-Greenberg C (2022) Clinical profiles of treated and untreated adults with hypophosphatasia in the Global HPP Registry. Orphanet J Rare Dis 17:277","journal-title":"Orphanet J Rare Dis"},{"key":"8161_CR39","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.metabol.2016.07.006","volume":"65","author":"TJ Weber","year":"2016","unstructured":"Weber TJ, Sawyer EK, Moseley S, Odrljin T, Kishnani PS (2016) Burden of disease in adult patients with hypophosphatasia: results from two patient-reported surveys. Metab Clin Exp 65:1522\u20131530","journal-title":"Metab Clin Exp"},{"key":"8161_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00198-023-06843-2","volume":"35","author":"E Rush","year":"2024","unstructured":"Rush E, Brandi ML, Khan A et al (2024) Proposed diagnostic criteria for the diagnosis of hypophosphatasia in children and adolescents: results from the HPP International Working Group. Osteoporos Int 35:1\u201310","journal-title":"Osteoporos Int"},{"issue":"1","key":"8161_CR41","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s11657-024-01441-z","volume":"19","author":"B Cortet","year":"2024","unstructured":"Cortet B, Guanabens N, Brandi ML, Siggelkow H (2024) Similarities and differences between European guidelines for the management of postmenopausal osteoporosis. Arch Osteoporos 19:84","journal-title":"Arch Osteoporos"},{"key":"8161_CR42","doi-asserted-by":"publisher","first-page":"e577","DOI":"10.1210\/clinem\/dgaf614","volume":"111","author":"BL Langdahl","year":"2026","unstructured":"Langdahl BL, Laursen NA, Makinen V, Harslof T, Solling AS (2026) Approach to the patient - transitions in osteoporosis therapy. J Clin Endocrinol Metab 111:e577\u2013e585","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-026-08161-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-026-08161-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-026-08161-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T12:00:39Z","timestamp":1794312039000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-026-08161-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["8161"],"URL":"https:\/\/doi.org\/10.1007\/s00198-026-08161-9","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"assertion":[{"value":"7 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}